首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway
【24h】

An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway

机译:通过抑制氧化应激和凋亡途径,从Clerodendrum粘液中分离的鞣果叶片改善了瑞士白化小鼠中的铁毒性诱导的肝毒性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Iron is a vital element required for normal cellular physiology in animal systems, but excess iron accumulation in the biological system accelerates oxidative stress, cellular toxicity, tissue injury and organ fibrosis, which ultimately leads to the generation of chronic liver diseases including cancer. A natural antioxidant, ellagic acid (EA) has been previously reported for its pharmacological properties; however, there is no significant evidence available that could illustrate its protective potential against iron-overload induced hepatotoxicity. In the present work, EA was evaluated for its in vitro free radical scavenging and iron chelation potentials. Further, EA was tested in vivo for its protective activity against iron overload-induced hepatotoxicity in Swiss albino mice by evaluating liver iron content, reactive oxygen species (ROS), liver antioxidant enzymes, serum marker levels, liver damage and fibrosis, histopathological study and finally western blotting analysis. EA treatment significantly decreased liver iron and serum ferritin levels. Elevated ROS levels, decreased antioxidant parameters and elevated serum markers were normalized upon treatment with EA. Cellular morphology, iron -overload and liver fibrosis were found to be effectively ameliorated. Finally, the protective effect of EA against iron overload-induced apoptosis was confirmed by western blotting when its treatment upregulated the expressions of caspase3 and poly(ADP-ribose) polymerase (PARP) proteins. EA revealed hepatoprotective activity against iron overload-induced toxicity through scavenging free radicals, inhibiting excess ROS production, normalizing liver damage parameters and upregulating caspase-3, PARP expression. Collectively, our findings support the possible use of the natural antioxidant EA as a promising candidate against iron-overloaded diseases.
机译:铁是动物系统中正常细胞生理学所需的重要元素,但生物系统中的铁积累过量加速氧化应激,细胞毒性,组织损伤和器官纤维化,最终导致包括癌症在内的慢性肝病的产生。先前已经报道了一种天然抗氧化剂,鞣酸(EA)的药理学特性;然而,没有有明显的证据可以说明其防止铁过载诱导的肝毒性的保护潜力。在目前的工作中,评估其体外自由基清除和铁螯合电位的EA。此外,通过评估肝脏铁含量,反应性氧物质(ROS),肝脏抗氧化酶,血清标志物水平,肝脏损伤和纤维化,组织病理学研究和血清损伤和纤维化,组织病理学研究和血清抗氧化酶最后是Western Blotting分析。 EA治疗显着降低了肝脏铁和血清铁蛋白水平。在用EA处理后,ROS水平升高,抗氧化参数和升高的血清标记物被标准化。发现细胞形态,铁 - 覆盖和肝纤维化有效地改善。最后,当其处理上调Caspase3和Poly(ADP-核糖)聚合酶(PARP)蛋白的表达时,通过Western印迹确认EA对铁过载诱导的细胞凋亡的保护作用。 EA通过清除自由基,抑制过量的ROS生产,促进肝脏损伤参数和上调Caspase-3,PARP表达,揭示了对铁过载引起的毒性的肝脏保护活性。集体,我们的研究结果支持自然抗氧化剂EA可能用作抗铁超载疾病的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号